Penny Stock Insider Trading
Tracking Executive Conviction in Stocks Under $5
Insider Activity in Low-Priced Equities
Insider trading in penny stocks often carries significant weight due to the high volatility inherent in smaller companies. When a director or CEO of a low-cap firm purchases shares, it can signal a major belief in an upcoming fundamental shift.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-05 00:37 | 2026-02-02 | GREE | Greenidge Generation Holdings Inc. | Mulvihill Christian | Officer - Chief Financial Officer | Finance Services | SELL | $1.28 | 1,958 | -$2,506 | 95,451 | -2.0% |
| 2026-02-05 00:36 | 2026-02-02 | GREE | Greenidge Generation Holdings Inc. | Irwin Dale | Officer - President | Finance Services | SELL | $1.28 | 1,985 | -$2,541 | 103,285 | -1.9% |
| 2026-02-05 04:08 | 2026-02-02 | EMPD | Empery Digital Inc. | ATG Capital Opportunities Fund LP | 10% owner | Motor Vehicles & Passenger Car Bodies | BUY | $4.68 | 691,145 | $3,232,485 | 4,500,000 | +18.1% |
| 2026-02-05 03:31 | 2026-02-02 | NOTE | FiscalNote Holdings, Inc. | Hwang Tim | Director, 10% owner | Services-Business Services, NEC | SELL | $1.20 | 4,090 | -$4,901 | 195,399 | -2.1% |
| 2026-02-05 05:20 | 2026-02-02 | NBRG | Newbridge Acquisition Ltd | Li Jining | Director, 10% owner | Blank Checks | BUY | $0.00 | 186,250 | $0 | 186,250 | +100.0% |
| 2026-02-05 05:21 | 2026-02-02 | NBRG | Newbridge Acquisition Ltd | Liu Yongsheng | Director, Officer, 10% owner - Chief Executive Officer | Blank Checks | BUY | $0.00 | 186,250 | $0 | 186,250 | +100.0% |
| 2026-02-05 01:20 | 2026-02-02 | ALLO | Allogene Therapeutics Inc. | Beneski Benjamin Machinas | Officer - SVP, Chief Technical Officer | Biological Products, (No Diagnostic Substances) | SELL | $1.73 | 7,549 | -$13,060 | 210,172 | -3.5% |
| 2026-02-05 01:09 | 2026-02-02 | ALLO | Allogene Therapeutics Inc. | Yoshiyama Annie | Officer - SVP, Finance | Biological Products, (No Diagnostic Substances) | SELL | $1.72 | 4,167 | -$7,167 | 130,322 | -3.1% |
| 2026-02-05 01:07 | 2026-02-02 | ALLO | Allogene Therapeutics Inc. | Roberts Zachary | Officer - EVP of R&D | Biological Products, (No Diagnostic Substances) | SELL | $1.77 | 35,700 | -$63,189 | 581,166 | -5.8% |
| 2026-02-05 04:27 | 2026-02-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | Officer - PAO and PFO | Pharmaceutical Preparations | SELL | $2.54 | 3,096 | -$7,875 | 186,730 | -1.6% |
| 2026-02-05 05:44 | 2026-02-02 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | Officer - See Remarks | Pharmaceutical Preparations | SELL | $2.20 | 18,442 | -$40,572 | 1,100,008 | -1.6% |
| 2026-02-05 00:52 | 2026-02-02 | ABSI | Absci Corporation | McClain Sean | Director, Officer - Chief Executive Officer | Services-Commercial Physical & Biological Research | SELL | $2.99 | 26,761 | -$80,015 | 8,334,567 | -0.3% |
| 2026-02-05 00:51 | 2026-02-02 | ABSI | Absci Corporation | Jonasson Zachariah | Officer - CFO / CBO | Services-Commercial Physical & Biological Research | SELL | $2.99 | 17,496 | -$52,313 | 383,538 | -4.4% |
| 2026-02-05 01:47 | 2026-02-04 | BCDA | BioCardia, Inc. | Altman Peter | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | BUY | $1.13 | 5,000 | $5,650 | 273,866 | +1.9% |
| 2026-02-05 00:32 | 2025-12-05 | BOLT | Bolt Biotherapeutics, Inc. | Quinn William P. | Director, Officer - President, CEO and CFO | Pharmaceutical Preparations | BUY | $4.61 | 125 | $576 | 2,313 | +5.7% |
| 2026-02-05 00:32 | 2025-12-05 | BOLT | Bolt Biotherapeutics, Inc. | Nemec Sarah | Officer - Senior VP, Finance and PAO | Pharmaceutical Preparations | BUY | $4.61 | 125 | $576 | 1,415 | +9.7% |
| 2026-02-05 01:18 | 2026-02-02 | ALLO | Allogene Therapeutics Inc. | Chang David D | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | SELL | $1.80 | 95,269 | -$171,484 | 5,185,862 | -1.8% |
| 2026-02-05 00:12 | 2026-02-02 | AKBA | Akebia Therapeutics Inc. | Rucci Carolyn M. | Officer - SVP, Chief Legal Officer | Pharmaceutical Preparations | SELL | $1.39 | 69,772 | -$96,983 | 588,378 | -10.6% |
| 2026-02-05 00:15 | 2026-02-02 | AKBA | Akebia Therapeutics Inc. | Malabre Richard C | Officer - SVP, Chief Accounting Officer | Pharmaceutical Preparations | SELL | $1.39 | 49,524 | -$68,838 | 299,390 | -14.2% |
| 2026-02-05 00:11 | 2026-02-02 | AKBA | Akebia Therapeutics Inc. | Ostrowski Erik | Officer - SVP, CFO, CBO & Treasurer | Pharmaceutical Preparations | SELL | $1.39 | 34,951 | -$48,582 | 672,635 | -4.9% |
| 2026-02-05 00:13 | 2026-02-02 | AKBA | Akebia Therapeutics Inc. | Grund Nicholas | Officer - Chief Commercial Officer | Pharmaceutical Preparations | SELL | $1.39 | 84,829 | -$117,912 | 561,750 | -13.1% |
| 2026-02-05 00:13 | 2026-02-02 | AKBA | Akebia Therapeutics Inc. | Burke Steven Keith | Officer - SVP, Chief Medical Officer | Pharmaceutical Preparations | SELL | $1.39 | 67,658 | -$94,045 | 948,432 | -6.7% |
| 2026-02-05 00:10 | 2026-02-02 | AKBA | Akebia Therapeutics Inc. | Butler John P. | Director, Officer - CEO and President | Pharmaceutical Preparations | SELL | $1.39 | 341,305 | -$474,414 | 3,297,794 | -9.4% |
| 2026-02-05 01:16 | 2026-02-02 | ALLO | Allogene Therapeutics Inc. | Parker Geoffrey M. | Officer - CHIEF FINANCIAL OFFICER | Biological Products, (No Diagnostic Substances) | SELL | $1.76 | 24,001 | -$42,242 | 1,252,795 | -1.9% |
| 2026-02-05 02:10 | 2026-02-02 | EXFY | Expensify, Inc. | Barrett David Michael | Director, Officer - Chief Executive Officer | Services-Prepackaged Software | SELL | $1.45 | 30,000 | -$43,500 | 1,318,480 | -2.2% |
| 2026-02-05 01:12 | 2026-02-02 | ALLO | Allogene Therapeutics Inc. | Douglas Earl Martin | Officer - SVP, General Counsel | Biological Products, (No Diagnostic Substances) | SELL | $1.76 | 22,900 | -$40,304 | 564,948 | -3.9% |
| 2026-02-05 03:17 | 2026-02-04 | ATYR | aTYR PHARMA INC | Shukla Sanjay | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | OPT+S | $0.98 | 3,745 | -$3,655 | 153,553 | 0.0% |
| 2026-02-05 03:12 | 2026-02-04 | ATYR | aTYR PHARMA INC | DENYES NANCY | Officer - General Counsel | Biological Products, (No Diagnostic Substances) | OPT+S | $0.98 | 1,118 | -$1,091 | 33,124 | 0.0% |
| 2026-02-05 03:15 | 2026-02-04 | ATYR | aTYR PHARMA INC | Broadfoot Jill Marie | Officer - Chief Financial Officer | Biological Products, (No Diagnostic Substances) | OPT+S | $0.98 | 1,558 | -$1,521 | 37,296 | 0.0% |
| 2026-02-04 16:16 | 2026-02-02 | OPHC | OptimumBank Holdings, Inc. | Terry Timothy | Officer - PEO | National Commercial Banks | SELL | $4.73 | 39,304 | -$185,908 | 0 | -100.0% |
| 2026-02-05 00:15 | 2026-02-02 | ALXO | Alx Oncology Holdings Inc. | GOODMAN COREY S | Director, 10% owner | Pharmaceutical Preparations | BUY | $1.57 | 3,184,713 | $4,999,999 | 8,453,038 | +60.5% |
| 2026-02-05 03:04 | 2026-02-04 | STEX | Streamex Corp. | GIUSTRA FRANK | 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $3.17 | 100,000 | $317,000 | 1,278,205 | +8.5% |
| 2026-02-04 20:13 | 2026-02-03 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.74 | 1,134 | $3,107 | 65,072 | +1.8% |
| 2026-02-05 05:03 | 2026-02-02 | FEED | ENvue Medical, Inc. | BANK OF AMERICA CORP /DE/ | 10% owner | Orthopedic, Prosthetic & Surgical Appliances & Supplies | SELL | $3.05 | 2,918 | -$8,906 | 231,138 | -1.2% |
| 2026-02-05 00:25 | 2026-02-02 | LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Global Management, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $1.30 | 1,538,462 | $2,000,001 | 1,538,462 | +100.0% |
| 2026-02-05 02:31 | 2026-02-04 | EGHT | 8X8 INC /DE/ | Middleton Hunter | Officer - Chief Product Officer | Services-Computer Processing & Data Preparation | SELL | $2.50 | 85,044 | -$212,814 | 652,943 | -11.5% |
| 2026-02-04 02:08 | 2026-02-03 | WPAC | White Pearl Acquisition Corp. | White Pearl Group Ltd | 10% owner | Blank Checks | BUY | $0.00 | 290,000 | $0 | 290,000 | +100.0% |
| 2026-02-04 03:39 | 2026-02-02 | BTM | Bitcoin Depot Inc. | Buchanan Christopher Scott | Director, Officer - Chief Executive Officer | Finance Services | SELL | $1.02 | 7,000 | -$7,140 | 605,276 | -1.1% |
| 2026-02-04 00:03 | 2026-02-02 | FEAM | 5E Advanced Materials, Inc. | Malm Joshua | Officer - CFO | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $2.00 | 3,750 | $7,500 | 5,175 | +263.2% |
| 2026-02-04 00:03 | 2026-02-02 | FEAM | 5E Advanced Materials, Inc. | Weibel Paul Wesley III | Officer - Chief Executive Officer | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $2.00 | 3,750 | $7,500 | 18,838 | +24.9% |
| 2026-02-04 04:08 | 2026-02-02 | DGXX | Digi Power X Inc. | Amar Alec | Director, Officer - President | Finance Services | SELL | $2.53 | 27,500 | -$69,575 | 1,263,116 | -2.1% |
| 2026-02-04 00:14 | 2026-02-02 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Director, Officer - President and CEO | Services-Commercial Physical & Biological Research | SELL | $0.50 | 113,297 | -$57,034 | 1,273,025 | -8.2% |
| 2026-02-03 20:46 | 2026-01-30 | FAT | Fat Brands, Inc | HOT GFG LLC | 10% owner | Retail-Eating Places | SELL | $0.27 | 1,794,766 | -$485,843 | 0 | -100.0% |
| 2026-02-04 00:00 | 2026-02-02 | HGBL | Heritage Global Inc. | Sklar James Edward | Officer - EVP, Gen Counsel & Secretary | Services-Business Services, NEC | SELL | $1.37 | 3,734 | -$5,116 | 268,593 | -1.4% |
| 2026-02-04 03:48 | 2026-01-31 | VIRT | Virtu Financial, Inc. | Cavoli Stephen | Officer - EVP | Security Brokers, Dealers & Flotation Companies | OPT+S | $0.00 | 43,551 | $0 | 199,461 | 0.0% |
| 2026-02-03 19:32 | 2026-02-03 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Director, 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $3.06 | 23,500 | $71,910 | 102,500 | +29.7% |
| 2026-02-03 20:35 | 2026-02-02 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer - Chief Scientific Officer | Pharmaceutical Preparations | OPT+S | $3.03 | 6,500 | -$19,680 | 0 | 0.0% |
| 2026-02-04 01:27 | 2026-01-30 | SNES | SenesTech, Inc. | GLENBROOK CAPITAL MANAGEMENT | 10% owner | Agricultural Chemicals | BUY | $1.96 | 48,138 | $94,524 | 593,785 | +8.8% |
| 2026-02-04 04:50 | 2026-01-23 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Longitude Capital Partners II, LLC | 10% owner | Laboratory Analytical Instruments | SELL | $4.36 | 108,739 | -$473,863 | 49,000 | -68.9% |
| 2026-02-04 02:01 | 2026-01-28 | WRAP | WRAP TECHNOLOGIES, INC. | NORRIS ELWOOD G | 10% owner | Ordnance & Accessories, (No Vehicles/Guided Missiles) | SELL | $2.32 | 148,020 | -$344,013 | 5,303,033 | -2.7% |
High Risk, High Reward Insider Trades
Penny stocks are notoriously volatile, but when insiders put their own money into stocks priced under $5, it provides a unique layer of validation. Unlike large-cap stocks where buys might be routine, a million-share purchase at $0.50 can indicate that management sees a path to recovery or exponential growth. Our tracking allows you to identify ini speculative signals in real-time, focusing on the capital flow of those with intimate industry knowledge. Following these low-cap moves helps bridge the information gap in the most volatile market segments.
Identifying Legitimate Micro-Cap Conviction
Our Penny Stock Filter isolates the most speculative yet promising filings from the SEC Form 4 feed. By focusing on low-priced equities, we highlight where CEOs and Directors are taking meaningful positions. This list is essential for small-cap investors looking to follow the capital of those with intimate knowledge of a company's research, patents, or upcoming regulatory approvals. Eliminate the noise and focus strictly on high-impact accumulation from leadership betting big on their company’s future value in the micro-cap space.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.